Tranexamic acid toxicity in human periarticular tissues

Bone and Joint Research

Volumn 8, Issue 1, 2019, Pages 11-18

  Mclean, M ^a,b   McCall, K ^a,b   Smith, I D M ^a,b   Blyth, M ^a,c   Kitson, S M ^a,b   Crowe, L A N ^a,b   Leach, W J ^a,c   Rooney, B P ^a,d   Spencer, S J ^a,d   Mullen, M ^a,d   Campton, J L ^a,d   McInnes, I B ^a,b   Akbar, M ^a   Millar, N L ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d QUEEN ELIZABETH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Cartilage; Periarticular tissues; Synovium; Tendon; Tranexamic acid

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; TRANEXAMIC ACID;

APOPTOSIS; ARTICLE; CARTILAGE; CELL DEATH; CELL VIABILITY; CELL VIABILITY ASSAY; CHONDROCYTE; CONTROLLED STUDY; CYTOTOXICITY; EXPLANT; FIBROBLAST; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; ORTHOPEDIC SURGERY; PRIMARY CELL CULTURE; SYNOVIOCYTE; SYNOVIUM; TENDON; TENOCYTE;

EID: 85060951473     PISSN: None     EISSN: 20463758     Source Type: Journal    
DOI: 10.1302/20463758.81.BJR20180181.R1     Document Type: Article

References (36)

1. Neveleff DJ, Kraiss LW, Schulman CS. Implementing methods to improve perioperative hemostasis in the surgical and trauma settings. AORN J 2010;92:S1-S15.
2. Carling MS, Jeppsson A, Eriksson BI, Brisby H. Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J Orthop Surg Res 2015;10:48.
3. Gandhi R, Evans HM, Mahomed SR, Mahomed NN. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes 2013;6:184.
4. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6:428-442.
5. Raut S, Mertes SC, Muniz-Terrera G, Khanduja V. Factors associated with prolonged length of stay following a total knee replacement in patients aged over 75. Int Orthop 2012;36:1601-1608.
6. Jahanshahi J, Hashemian F, Pazira S, et al. Effect of topical tranexamic acid on bleeding and quality of surgical field during functional endoscopic sinus surgery in patients with chronic rhinosinusitis: a triple blind randomized clinical trial. PLoS One 2014;9:e104477.
7. Poeran J, Rasul R, Suzuki S, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ 2014;349:g4829.
8. Morrison RJM, Tsang B, Fishley W, et al. Dose optimisation of intravenous tranexamic acid for elective hip and knee arthroplasty: the effectiveness of a single pre-operative dose. Bone Joint Res 2017;6:499-505.
9. Dyba J, Chan FC, Lau KK, Chan AK, Chan HW. Tranexamic acid is a weak provoking factor for thromboembolic events: a systematic review of the literature. Blood2013;122:3629.
10. Wong MW, Lui WT, Fu SC, Lee KM. The effect of glucocorticoids on tendon cell viability in human tendon explants. Acta Orthop 2009;80:363-367.
11. Gilbody J, Dhotar HS, Perruccio AV, Davey JR. Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty. J Arthroplasty 2014;29:681-684.
12. Kjolseth D, Frank JM, Barker JH, et al. Comparison of the effects of commonly used wound agents on epithelialization and neovascularization. J Am Coll Surg 1994;179:305-312.
13. Sitek P, Wysocka-Wycisk A, Ke pski F, et al. PRP-fibrinogen gel-like chondrocyte carrier stabilized by TXA-preliminary study. Cell Tissue Bank 2013;14:133-140.
14. Ambra LF, de Girolamo L, Niu W, et al. No effect of topical application of tranexamic acid on articular cartilage. Knee Surg Sports Traumatol Arthrosc 2017. (Epub ahead of print). PMID: 29119286.
15. Marmotti A, Mattia S, Mangiavini L, et al. Tranexamic acid effects on cartilage and synovial tissue: an in vitro study for a possible safe intra-articular use. J Biol Regul Homeost Agents 2016;30(Suppl 1):33-40.
16. Parker JD, Lim KS, Kieser DC, Woodfield TBF, Hooper GJ. Is tranexamic acid toxic to articular cartilage when administered topically? Bone Joint J 2018:100-B:404-412.
17. Tuttle JR, Feltman PR, Ritterman SA, Ehrlich MG. Effects of tranexamic acid cytotoxicity on in vitro chondrocytes. Am J Orthop 2015;44:E497-E502.
18. Kuo CK, Marturano JE, Tuan RS. Novel strategies in tendon and ligament tissue engineering: advanced biomaterials and regeneration motifs. Sports Med Arthrosc Rehabil Ther Technol 2010;2:20.
19. Muir H. The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. BioEssays 1995;17:1039-1048.
20. Outerbridge RE, Dunlop JA. The problem of chondromalacia patellae. Clin Orthop Relat Res 1975;110:177-196.
21. Millar NL, Gilchrist DS, Akbar M, et al. MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease. Nat Commun 2015;6:6774.
22. Hui W, Litherland GJ, Jefferson M, et al. Lithium protects cartilage from cytokine-mediated degradation by reducing collagen-degrading MMP production via inhibition of the P38 mitogen-activated protein kinase pathway. Rheumatology (Oxford) 2010;49:2043-2053.
23. Karaaslan F, Seijas R, Sallent A, et al. Tranexamic acid in bolus alone vs bolus and continuous infusion in hip arthroscopy. Int J Orthop 2017;4:749-752.
24. Yu CC, Gao WJ, Yang JS, et al. Can tranexamic acid reduce blood loss in cervical laminectomy with lateral mass screw fixation and bone grafting: a retrospective observational study. Medicine (Baltimore) 2017;96:e6043.
25. Karaaslan F, Karaoglu S, Yurdakul E. Reducing intra-articular hemarthrosis after arthroscopic anterior cruciate ligament reconstruction by the administration of intravenous tranexamic acid: a prospective, randomized controlled trial. Am J Sports Med 2015;43:2720-2726.
26. Patel JN, Spanyer JM, Smith LS, et al. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study. J Arthroplasty 2014;29:1528-1531.
27. Drosos GI, Ververidis A, Valkanis C, et al. A randomized comparative study of topical versus intravenous tranexamic acid administration in enhanced recovery after surgery (ERAS) total knee replacement. J Orthop 2016;13:127-131.
28. Ishida K, Tsumura N, Kitagawa A, et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 2011;35:1639-1645.
29. Wong J, Abrishami A, El Beheiry H, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg [Am] 2010;92-A:2503-2513.
30. Chiang E-R, Ma H-L. Intra-articular injection of tranexamic acid for reducing postoperative hemarthrosis in arthroscopic anterior cruciate ligament reconstruction [poster]. ISAKOS Congress, 2017.
31. Kunugiza Y, Nakamura Y, Mikami K, Suzuki S. Warfarin-related recurrent knee haemarthrosis treated with arterial embolisation and intra-articular injection of tranexamic acid. BMJ Case Rep 2015;2015.
32. Mutsuzaki H, Ikeda K. Intra-articular injection of tranexamic acid via a drain plus drain-clamping to reduce blood loss in cementless total knee arthroplasty. J Orthop Surg Res 2012;7:32.
33. Sabatini L, Atzori F. Topical intra-articular and intravenous tranexamic acid to reduce blood loss in total knee arthroplasty. Ann Transl Med 2015;3(Suppl 1):S18.
34. Tahmasebi MN, Bashti K, Ghorbani G, Sobhan MR. Intraarticular administration of tranexamic acid following total knee arthroplasty: a case-control study. Arch Bone Jt Surg 2014;2:141-145.
35. Zhang Y, Fu X, Liu WX, et al. Safety and efficacy of intra-articular injection of tranexamic acid in total knee arthroplasty. Orthopedics 2014;37:e775-e782.
36. Ahlberg A, Eriksson O, Kjellman H. Diffusion of tranexamic acid to the joint. Acta Orthop Scand 1976;47:486-488.